For the first time, the Accreditation Council for CME is initiating a review of the commercial support system that will include considering a full range of options — from leaving the process intact, to setting up a centralized grants repository, to limiting — and even prohibiting — pharmaceutical industry funding of CME. “It's hard to believe that we could be talking about not having commercial support — we wouldn't have talked about that 10 years ago,” says Murray Kopelow, MD, ACCME chief ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the ACCME Responds to Senate, you'll also gain access to exclusive premium content.

Already registered? here.